INITIAL PATIENT INTAKE FORM

Similar documents
INITIAL PATIENT INTAKE FORM

PATIENT INTAKE FORM. Name: Address: Town: State: Zip Code: MMJ Card #: Exp. Date: Drivers License #: Exp. Date: Home Phone: Cell:

PATIENT QUESTIONNAIRE

Medical Marijuana Consent Form

SNA MEDICAL PC Sheepshead Bay Rd Brooklyn, NY Acknowledgements, Agreements, Disclosures and Informed Consent

99 SOUTH ALCANIZ STREET SUITE B PENSACOLA, FL

Welcome to MedWell. MedWell Health and Wellness Centers. Don t live with PAIN Live WELL MedWell. o Newspaper o Referred by.

17822 Beach Blvd, Suite 330 Phone: (714) Huntington Beach, CA Fax: (714) Patient Information Form.

PATIENT QUESTIONNAIRE

PATIENT QUESTIONNAIRE

NEW JERSEY ALTERNATIVE MEDICINE ANDREW MEDVEDOVSKY, M.D. Patient Intake Form

Welcome to MedWell. Patient Information. Name: Address: City: State: Zip Code: !Other. Name: Address: City: State:

Eastern Shore MediCann Clinic, LLC

MEDICATION GUIDE Valproic Acid (val pro ic acid) Capsules

FDA APPROVED MEDICATION GUIDE

Scottsdale Certification Center Health History Questionnaire. Name Gender M / F Date. Date of Birth / / Phone Ht: ft in Wt. Residential Address

DIVALPROEX (di val pro ex) SODIUM DELAYED-RELEASE TABLETS, USP

Membership Package Checklist

Medication Guide Clonazepam Tablets USP (kloe-na-za-pam)

Venlafaxine hydrochloride extended-release and other antidepressant medicines may cause serious side effects, including:

YOUR GUIDE TO TECENTRIQ (atezolizumab) non-small cell lung cancer (NSCLC)

Consumer Information Cannabis (Marihuana, marijuana)

MEDICATION GUIDE LAMOTRIGINE TABLETS

MEDICATION GUIDE. The risk of getting a serious skin rash is higher if you:

Joseph S. Weiner, MD, PC Patient History Form

LGP CLASSIC Oil Products

the natural choice Page 1

What else do I need to know about antidepressant medicines?

PATIENT FEE SCHEDULE As of January 1, 2017

MEDICATION GUIDE WELLBUTRIN (WELL byu-trin) (bupropion hydrochloride) Tablets

For the Patient: USMAVNIV

Discussing TECENTRIQ (atezolizumab) with your healthcare team

MEDICATION GUIDE. Peganone 250 mg Tablets (PEG-ah-noan) (ethotoin tablets, USP)

PATIENT BASIC INFORMATION FORM (To be filled out by patient)

For the Patient: ULUAVPMB

PACKAGE LEAFLET: INFORMATION FOR THE USER

Diana Quinn, ND Integrative Healthcare Providers 3053 Miller Rd Ann Arbor, MI P (734) F (734) New Patient Intake Form

PATIENT MEDICAL HISTORY INTAKE FORM

MEDICATION GUIDE TOPIRAMATE

(topiramate) Tablets and Sprinkle Capsules

NHS Greater Glasgow And Clyde Pain Management Service. Information for Adult Patients who are Prescribed. Pregabalin. For the Treatment of Pain

NEW PATIENT CONSULTATION Worksheet

MEDICATION GUIDE. Quetiapine (kwe-tye-a-peen) Tablets USP

MEDICATION GUIDE Savella (Sa-vel-la) (milnacipran HCl) Tablets

For the Patient: USMAVFIPI

MEMBERSHIP OVERVIEW. To become a member at Warmland, you must provide documentation confirming you fall into at least one of the following categories:

Richard Senysyzn, MD Psychiatry for Adults 1260 River Acres Drive New Braunfels, TX , Fax. (888)

Health Profile. Last Name: First Name: Address: Apt/Unit: # City: State: Zip/Postal Code: Phone: Cell:

FDA-approved Medication Guide MEDICATION GUIDE. RIBASPHERE (Rīb-ă-sphere) Tablets

Medical Cannabis: A Patient Primer

Medical Marijuana Update Chris Belletieri, DO

Name Date / / Age Male/Female Address City State Zip Phone: Home Cell Carrier (Ex: AT&T, Verizon)

Weight 1 year ago (lb):

Apt. /unit: City: State: Zip Code:

New Patient Medical History and Intake Form Medical Marijuana ( MMJ ) Certification

For the Patient: USMAVPEM

PATIENT REGISTRATION PERSON TO NOTIFY IN CASE OF EMERGENCY. Name: Relationship: Phone:

IMPORTANT: PLEASE READ

attempts to commit suicide acting aggressive, being angry, or violent

PATIENT REGISTRATION PERSON TO NOTIFY IN CASE OF EMERGENCY. Name: Relationship: Phone:

MEDICATION GUIDE WELLBUTRIN (WELL byu-trin) (bupropion hydrochloride) Tablets

CDHA 2016 Fall Symposium. Speaker Handout Files. For registered attendees only

17.9 Food Patients may take STRATTERA with or without food.

Objectives. 1. Review controversy 2. Pathophysiology 3. Indications for Use 4. Adverse Effects 5. How Patients Access

Patient Name: Date of Birth: Patient Name: DOB: Patient Guardian/Representative: How old are you. Handed: Right Left Ambidextrous Male

NHS Greater Glasgow And Clyde Pain Management Service. Information for Adult Patients who are Prescribed. Carbamazepine. For the Treatment of Pain

Southwest Medical Marijuana Evaluation Center

Elements for a public summary

New Patient Information & Consents

Medical condition SELF Mother Father Sibling (list brother or sister) Anxiety Bipolar disorder Heart Disease Depression Diabetes High Cholesterol

MEDICAL DATA SHEET For Patients 18 years of age and older

MEDICATION GUIDE ONFI (ON-fee) (clobazam) Tablets and Oral Suspension

Discussing TECENTRIQ (atezolizumab) with your healthcare team Talking to Your Doctor

GUPTA SPORTS & SPINE CENTER

New Patient Form. Patient Demographics. Emergency Information. Employment Information. Page 1 of 7. Family Health Chiropractic Care

Intake Forms for New Patients

PATIENT AUTHORIZATION AND NOTICE OF RELEASE OF INFORMATION (PAN)

Reference ID:

Evolve180 / Ideal Northwest Health Profile

HEALTH RECORD REASON FOR THIS VISIT ABOUT YOU ABOUT YOUR SPOUSE HEALTH HABITS EXPERIENCE WITH CHIROPRACTIC

Shirley Gutkowski, RDH, BSDH. Primary OMT Practitioner and Breathing Re-training Instructor 1266 W. Main Street Sun Prairie, WI

New Patient Information

Who may we thank for referring you? Office Only LIST YOUR HEALTH CONCERNS BELOW. If you had the condition before, when? When did this episode start?

Psychiatric Evaluation Intake Form

Corinna Mosher, M.D. A Medical Corporation 415 E. Rolling Oaks Drive Suite #280 Thousand Oaks, CA (805) Fax (805)

MEDICATION GUIDE LAMICTAL

MEDICATION GUIDE Mefloquine Hydrochloride Tablets, USP

What Cities Need to Know about the Arkansas Medical Marijuana Amendment ( AMMA ) 1

Surgical History Please list all operations and dates:

DESCRIPTION DURATION

Minnesota. Prescribing and Dispensing Profile. Research current through November 2015.

Name: Date: Street Address: Referring Physician: How long have you had your current problem?

MEDICATION GUIDE BuPROPion Hydrochloride Extended-Release Tablets, USP (SR) (byoo-proe-pee-on)

IMIPENEM+CILASTATIN RBX

DISCOVER INVEGA TRINZA

Patient Information VERSACLOZ (VER sa kloz) (clozapine) Oral Suspension

MEDICATION GUIDE Quetiapine Fumarate Extended-Release Tablets (Kwe-TYE-a-peen FUE-ma-rate)

Transcription:

INITIAL PATIENT INTAKE FORM Name: (Please, print legibly) Registry ID: Date of Birth: MM / DD / YYYY Gender: Male Female Address: Town: State: Zip Code: Preferred method of contact. For internal promotional use only. Home Phone: Morning Afternoon Evening Cell Phone: Morning Afternoon Evening Carrier (e.g. Verizon, AT&T): Email: Primary Care Physician: TCP Authorized Physician: Doctor who qualified you for the Therapeutic Cannabis Program Registered Caregiver (if applicable): Phone Number: A Registered Caregiver is a person chosen by the patient to act as their agent in obtaining their medication at the dispensary. If you feel that you need a caregiver, please inquire with a receptionist. Are you a veteran? (Please check one) Yes No *IF YES, PLEASE PROVIDE DOCUMENTATION FOR A 10% DISCOUNT ON PURCHASES* Are you pregnant, planning to become pregnant or breastfeeding? Yes No N/A How did you hear about us? Website Department of Health and Human Services News Article Leafly Referred Search Engine 1

My State Approved Condition(s): (Please check what applies below) Acquired Immune Deficiency Syndrome Alzheimer s Disease Amyotrophic Lateral Sclerosis Cachexia Cancer Chemotherapy-Induced Anorexia Chronic Pancreatitis Crohn s Disease Ehlers-Danlos Syndrome Epilepsy Glaucoma Hepatitis C Moderate to Severe Chronic Pain Moderate to Severe Post-Traumatic Stress Disorder Multiple Sclerosis Muscular Dystrophy Parkinson s disease Positive Status for Human Immunodeficiency Virus Spinal Cord Injury or Disease Traumatic Brain Injury Ulcerative Colitis Wasting Syndrome Lupus Please Note: Additional conditions will be added over time, please check the Department of Health and Human Services website for changes to the list at https://www.dhhs.nh.gov/oos/tcp/ Additional Health Conditions: Positive outcomes I hope to achieve using Therapeutic Cannabis: 2

Negative symptoms that I am currently experiencing: (Please check what applies below) Abdominal Pain / Cramping Anxiety Back Pain Chest Pains Depression Difficulty Falling / Staying Asleep Dizziness Elevated Ocular Pressure Fatigue Headaches Heartburn / Reflux Hyperactive Bowels Inflammation Irritability Memory Changes Migraine Muscle Cramps Muscle Spasms / Tremors Nausea Numbness / Tingling Pain Painful Muscles Painful / Swollen Joints Panic Attacks Paranoia Poor Appetite Seizures Shortness of Breath Sleep Apnea Trouble with Balance Vomiting Weakness Other: 3

Current Medication(s) Dosage Allergies: Alternative Medicine(s) Vitamins Do you take Medications for the following conditions? (Please circle one) Blood Pressure Immune Disorder Organ Transplant Hyperthyroidism Hypothyroidism Diabetes Mellitus I Diabetes Mellitus II High Cholesterol Nerve Pain Heart Condition 4

Do you smoke tobacco? (Please check one): Yes No Do you drink alcohol? (Please check one): Yes No Do you live alone? (Please check one): Yes No Are you currently employed? (Please check one): Is there a time of day that your symptoms seem to be worse? (Please describe, If applicable) Yes No Have you used Therapeutic Cannabis/Cannabis prior to this visit? Yes No N/A If yes, How Often are you Using Therapeutic Cannabis/Cannabis and How Has it Helped You? Please describe, If applicable Positive Effects Experienced using Therapeutic Cannabis (if applicable): Negative Effects Experienced using Therapeutic Cannabis (if applicable): My Preferred Method of Therapeutic Cannabis Consumption: (Please check what applies below) Inhalation (Smoking) Vaporizing Consumables (Edibles) Oils Tincture Concentrates I am uncertain Other: 5

NOTICE OF PRIVACY PRACTICES PATIENT ACKNOWLEDGEMENT Patient Name: Date of Birth: I understand, that under the Health Insurance Portability Act of 1996, I have certain rights to privacy in regards to my protected health information (PHI). I have received, read, and understand the Notice of Privacy Practices. Prime Alternative Treatment Centers reserves the right to change the terms of its Notice of Privacy Practices. I understand Prime Alternative Treatment Centers will provide a current Notice of Privacy Practices. Patient Signature: Authorized Patient s Representative: Relationship: Signature: -------------------------------------------------------------------- FOR OFFICE USE ONLY ------------------------------------------------------------------------- I was unable to obtain the patient / patient s representative s signature. Employee s Name: Reason: 6

Acknowledgement of Disclosure and Assumption of Risk Agreement This Acknowledgement of Disclosure and Assumption of Risk Agreement has been prepared to provide you with information regarding the risks and side effects of using Therapeutic Cannabis. It is important that you read this information carefully and completely. Please discuss any questions you may have with the dispensary technician or your certifying physician. Once you have read and understand the attached information, and have had any questions addressed to your satisfaction, please sign and date the Acknowledgement of Disclosure and Assumption Risk Agreement. Do not sign this Agreement and do not use Therapeutic Cannabis if you have questions about or do not understand the information you have received or are not willing to assume all the risks that may be associated with Therapeutic Cannabis use or possession. Risks and Side Effects of Therapeutic Cannabis Use Possession or use of this product is unlawful outside of the State of New Hampshire and prohibited by Federal law. Therapeutic Cannabis may have intoxicating effects and has not been analyzed or approved by the United States Food and Drug Administration ( FDA ) and was produced without FDA oversight for health, safety, or efficacy. Therapeutic Cannabis may contain unknown quantities of active ingredients, impurities, or contaminants. The efficacy and potency of therapeutic cannabis may vary widely depending on the Therapeutic Cannabis strain and ingestion method. If Therapeutic Cannabis is smoked or vaporized: Smoking may be hazardous to your health. Therapeutic Cannabis smoke contains carcinogens and may lead to an increased risk of cancer, tachycardia, hypertension, heart attack, birth defects, brain damage, and lung disease. If Therapeutic Cannabis is eaten or swallowed: When products infused with therapeutic cannabis or active compounds of therapeutic cannabis are eaten or swallowed, the intoxicating effects of this drug may be delayed by two or three hours or more. There is limited information on the side effects of using Therapeutic Cannabis, and there may be associated health risks. Side effects of Therapeutic Cannabis can include, but are not limited to: Memory loss Anxiety/Nervousness Dry mouth Irregular/Increased heartbeat Sexual impotence Hunger/Loss of appetite Dizziness/Impairment of motor skills Cough/Bronchitis/Shortness of Breath Dependency Poor physical condition Depression 7

Numbness Low blood pressure Agitation Confusion Headache/Nausea/Vomiting Sedation/slower reaction time/inability to concentrate Impaired vision Feelings of euphoria Laryngitis/Bronchitis/General Apathy Drowsiness/Fatigue/Abnormal sleep Paranoia/Psychotic Symptoms Suppression of immune system Symptoms of Therapeutic Cannabis overdose include, but are not limited to, nausea, vomiting, and disturbances to heart rhythm. The scientific basis for the medical use of Therapeutic Cannabis has not been established. There is little known information regarding how Therapeutic Cannabis may or may not react with other pharmaceutical or herbal medications. Some patients can become dependent on Therapeutic Cannabis. This means they experience withdrawal symptoms when they stop using Therapeutic Cannabis. Signs of withdrawal symptoms can include feelings of depression, sadness or irritability, restlessness or mild agitation, insomnia, sleep disturbance, unusual tiredness, trouble concentrating, and loss of appetite. Some users can develop a tolerance to Therapeutic Cannabis. This means higher and higher doses are required to achieve the same symptom relief. The possibility exists that Therapeutic Cannabis may exacerbate schizophrenia or bipolar disorder in persons predisposed to those disorders. Woman should not consume Therapeutic Cannabis products while planning to become pregnant, during pregnancy, or while breast feeding, except on the advice of the certifying health practitioner, and in the case of breast feeding mothers, on the advice of the infant s pediatrician. Keep out of the reach of children and pets. Using Therapeutic Cannabis while under the influence of alcohol is not recommended. The use of Therapeutic Cannabis may affect coordination, cognition, and judgement. While under the influence of Therapeutic Cannabis, do not drive, operate machinery, or engage in potentially hazardous activities. Please note that medical marijuana will degrade over time. I certify that I have read the above Acknowledgment Disclosure and Assumption of Risk Agreement and I fully understand any potential risks and side effects related to the use of Therapeutic Cannabis. In using Therapeutic Cannabis for medicinal use, I fully accept responsibility and assume any risks and side effects associated with its use. I further hold harmless and release Prime Alternative Treatment Centers of any liability related to any risks. Patient Signature: Patient Name: 8

Therapeutic Cannabis Program Patient Agreement I agree that the following statements are true and accurate: I am registered with and understand the requirements of the State of New Hampshire s Therapeutic Cannabis Program. I agree to strictly comply with the regulations, terms and conditions of the State of New Hampshire s Therapeutic Cannabis Program including, but not limited to, ensuring that no Therapeutic Cannabis obtained by me shall be used for any other purpose than as directed by my certifying physician and such therapeutic cannabis is not resold, distributed, or otherwise possessed or used by any other person. I have been advised of the possible risks and side effects associated with using Therapeutic Cannabis by my certifying physician and dispensing pharmacist and have decided to assume such risks. If I start using Therapeutic Cannabis, I agree to tell my physician if I experience any one or more of the following: Start to feel sad or have crying spells Have changes in my normal sleep patterns Lose my appetite Become more irritable than usual Become unusually tired Withdraw from my family and friends Lose interest in my usual activities Any other side effects included in but not limited to the Acknowledgement of Disclosure of Risk Agreement In the event that I experience a severe adverse reaction, I agree to immediately contact my physician. In the event that my physician is not available, I agree to call 911 for help. I agree to tell my physician if I have ever had symptoms of schizophrenia, bipolar disorder, psychotic episodes or have attempted suicide. I also agree to tell my physician if I have ever been prescribed or taken medication for any of these conditions. I acknowledge that the risks of using Therapeutic Cannabis under these circumstances could be severe. I understand that my PATC (Prime Alternative Treatment Centers) does not suggest nor condone that I cease treatment of medications that stabilize my mental or physical condition. I am not pregnant, intending to become pregnant, or breastfeeding. I certify that I have read this Therapeutic Cannabis Program Patient Agreement and declare that the information contained herein is true, correct, and complete. Patient Signature: Patient Name: 9